Michael A Hagler

1.0k total citations · 1 hit paper
20 papers, 813 citations indexed

About

Michael A Hagler is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael A Hagler has authored 20 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 6 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael A Hagler's work include Cardiac Valve Diseases and Treatments (10 papers), Mitochondrial Function and Pathology (5 papers) and Cardiac tumors and thrombi (4 papers). Michael A Hagler is often cited by papers focused on Cardiac Valve Diseases and Treatments (10 papers), Mitochondrial Function and Pathology (5 papers) and Cardiac tumors and thrombi (4 papers). Michael A Hagler collaborates with scholars based in United States, United Kingdom and India. Michael A Hagler's co-authors include Jordan D. Miller, Carolyn M Roos, Nassir M Thalji, Grace Casaclang‐Verzosa, Tamar Pirtskhalava, Yi Zhu, James L. Kirkland, Bin Zhang, Diana Jurk and Mikołaj Ogrodnik and has published in prestigious journals such as Circulation, The FASEB Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Michael A Hagler

19 papers receiving 799 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice

2016 564 citations Carolyn M Roos, Bin Zhang et al. Aging Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A Hagler United States	6	380	293	185	150	116	20	813
Carolyn M Roos United States	7	467 1.2×	280 1.0×	191 1.0×	128 0.9×	117 1.0×	26	949
Eric van der Veer Canada	7	204 0.5×	278 0.9×	71 0.4×	75 0.5×	31 0.3×	7	748
James Wordsworth United Kingdom	4	451 1.2×	298 1.0×	209 1.1×	13 0.1×	98 0.8×	8	773
Lia R. Edmunds United States	16	163 0.4×	468 1.6×	144 0.8×	70 0.5×	11 0.1×	22	912
Junkun Zhan China	22	229 0.6×	866 3.0×	172 0.9×	132 0.9×	19 0.2×	51	1.5k
Lana Corbo United States	6	343 0.9×	315 1.1×	147 0.8×	11 0.1×	111 1.0×	7	686
Daniel Rivas Canada	16	175 0.5×	635 2.2×	125 0.7×	112 0.7×	9 0.1×	26	1.2k
Pan Tan China	15	169 0.4×	408 1.4×	72 0.4×	65 0.4×	13 0.1×	20	744
Michael S. Goligorsky United States	12	215 0.6×	354 1.2×	73 0.4×	84 0.6×	10 0.1×	16	732
Kwan Hyuck Baek South Korea	5	359 0.9×	584 2.0×	122 0.7×	92 0.6×	10 0.1×	5	997

Countries citing papers authored by Michael A Hagler

Since Specialization

Citations

This map shows the geographic impact of Michael A Hagler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A Hagler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A Hagler more than expected).

Fields of papers citing papers by Michael A Hagler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A Hagler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A Hagler. The network helps show where Michael A Hagler may publish in the future.

Co-authorship network of co-authors of Michael A Hagler

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A Hagler. A scholar is included among the top collaborators of Michael A Hagler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A Hagler. Michael A Hagler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Roos, Carolyn M, Michael A Hagler, Bin Zhang, et al.. (2023). Abstract 460: Catalase Overexpression Modulates Plaque Fibrosis And Vascular Contractile Function In Aged Hyperlipidemic Mice. Arteriosclerosis Thrombosis and Vascular Biology. 43(Suppl_1). 1 indexed citations

Roos, Carolyn M, Bin Zhang, Michael A Hagler, Arman Arghami, & Jordan D. Miller. (2021). MnSOD protects against vascular calcification independent of changes in vascular function in hypercholesterolemic mice. Atherosclerosis. 331. 31–37. 2 indexed citations

Zhang, Bin, et al.. (2021). Sirtuin 6 Protects Against Oxidative Stress and Vascular Dysfunction in Mice. Frontiers in Physiology. 12. 753501–753501. 16 indexed citations

Roos, Carolyn M, Bin Zhang, Michael A Hagler, et al.. (2021). Effects of Altering Mitochondrial Antioxidant Capacity on Molecular and Phenotypic Drivers of Fibrocalcific Aortic Valve Stenosis. Frontiers in Cardiovascular Medicine. 8. 694881–694881. 4 indexed citations

Zhang, Bin, Carolyn M Roos, Michael A Hagler, et al.. (2019). Abstract 123: Activation of Oxidized Soluble Guanylate Cyclase Slows Progression of Aortic Valve Calcification. Arteriosclerosis Thrombosis and Vascular Biology. 39(Suppl_1). 3 indexed citations

Roos, Carolyn M, et al.. (2018). Paradoxical Effects of Overexpressing Human Catalase on Vascular Function and Atherosclerotic Plaque Composition in Hypercholesterolemic Mice. The FASEB Journal. 32(S1).

Roos, Carolyn M, Michael A Hagler, Nassir M Thalji, et al.. (2017). Abstract 249: Potential Tissue-specific Interactions Between Inflammation and Canonical Tgfβ Signaling in Marfan Syndrome. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations

Roos, Carolyn M, Michael A Hagler, Grace Verzosa, et al.. (2017). Abstract 427: Histopathological and Molecular Effects of SIRT3 Deletion in Advanced Calcific Aortic Valve Disease. Arteriosclerosis Thrombosis and Vascular Biology. 37(suppl_1). 1 indexed citations

Roos, Carolyn M, Bin Zhang, Allyson K. Palmer, et al.. (2016). Chronic senolytic treatment alleviates established vasomotor dysfunction in aged or atherosclerotic mice. Aging Cell. 15(5). 973–977. 564 indexed citations breakdown →

10.

Roos, Carolyn M, Michael A Hagler, Bin Zhang, & Jordan D. Miller. (2016). Effects of SIRT3 deficiency on vasomotor function and atherosclerotic plaque composition in mice. The FASEB Journal. 30(S1). 4 indexed citations

11.

Roos, Carolyn M, et al.. (2016). Genetic Inactivation of DNMT3b Protects Against Activation of Osteogenic Signaling and Slows Progression of Aortic Valve Stenosis in Mice. The FASEB Journal. 30(S1). 3 indexed citations

12.

Thalji, Nassir M, Michael A Hagler, Grace Verzosa, Rakesh M. Suri, & Jordan D. Miller. (2015). Evidence for time‐dependent and adaptive mechanisms in the mitral valve following prolonged Angiotensin II infusion. The FASEB Journal. 29(S1). 1 indexed citations

13.

Roos, Carolyn M, Michael A Hagler, Bin Zhou, et al.. (2015). Abstract 582: Overexpression of Mnsod Reduces Aortic Valve Calcification Through Repression of Pro-osteogenic Signaling. Arteriosclerosis Thrombosis and Vascular Biology. 35(suppl_1). 1 indexed citations

14.

Hagler, Michael A, Nassir M Thalji, Michael Welge, et al.. (2015). Abstract 19746: Identification of Novel microRNA Profiles in Patients With Myxomatous Mitral Valve Disease. Circulation. 132(suppl_3). 4 indexed citations

15.

Thalji, Nassir M, Michael A Hagler, Heyu Zhang, et al.. (2015). Nonbiased Molecular Screening Identifies Novel Molecular Regulators of Fibrogenic and Proliferative Signaling in Myxomatous Mitral Valve Disease. Circulation Cardiovascular Genetics. 8(3). 516–528. 42 indexed citations

16.

Hagler, Michael A, et al.. (2014). Evidence for altered DNA methylation as a major regulator of gene expression in calcific aortic valve disease (671.15). The FASEB Journal. 28(S1). 6 indexed citations

17.

Roos, Carolyn M, Bin Zhang, Grace Verzosa, et al.. (2014). Abstract 27: Role of Sirtuin 6 in the Initiation and Progression of Calcific Aortic Valve Disease. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 4 indexed citations

18.

Hagler, Michael A, Heyu Zhang, Carolyn M Roos, et al.. (2013). TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves. Cardiovascular Research. 99(1). 175–184. 117 indexed citations

19.

Roos, Carolyn M, Michael A Hagler, Bin Zhang, et al.. (2013). Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice. American Journal of Physiology-Heart and Circulatory Physiology. 305(10). H1428–H1439. 38 indexed citations

20.

Hagler, Michael A, et al.. (2011). IL‐10 suppresses pro‐fibrotic and matrix remodeling genes in normal and myxomatous mitral valves. The FASEB Journal. 25(S1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact